You are about to leave the website of Otsuka Novel Products GmbH and view the content of an external website. Otsuka Novel Products GmbH cannot be held responsible for the content of external websites.
Treatment of TB entails taking multiple medicines together for many months. Whenever a new medicine appears, it should be tested with the other anti-TB medicines to ensure that the combination gives the optimal balance between efficacy and safety.
Otsuka is involved in multiple research collaborations examining various treatment regimens, in order to find the shortest, most effective, and most patient-friendly way to treat multidrug-resistant TB. Such a resistant form of TB requires long and sometimes complicated treatment.
Information current as of 26-06-2017
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.